Cargando…

Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy

Detalles Bibliográficos
Autores principales:	von Schaewen, Markus, Ploss, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301267/ https://www.ncbi.nlm.nih.gov/pubmed/28210676 http://dx.doi.org/10.1016/j.jcmgh.2015.03.005

Ejemplares similares

Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
por: von Schaewen, Markus, et al.
Publicado: (2016)

Barriers of hepatitis C virus interspecies transmission
por: Sandmann, Lisa, et al.
Publicado: (2013)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
por: Stoddard, Mark B., et al.
Publicado: (2015)

Animal Models Used in Hepatitis C Virus Research
por: Berggren, Keith A., et al.
Publicado: (2020)

Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection
por: Singal, Ashwani Kumar
Publicado: (2010)

Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
por: Cho, Eun Ju, et al.
Publicado: (2016)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

Hepatitis E Virus Replication
por: LeDesma, Robert, et al.
Publicado: (2019)

Mechanism of Hepatitis B Virus cccDNA Formation
por: Wei, Lei, et al.
Publicado: (2021)

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?
por: Vogel, Wolfgang
Publicado: (2004)

Recent advances in understanding hepatitis C
por: Douam, Florian, et al.
Publicado: (2016)

Role of viral and host factors in interferon based therapy of hepatitis C virus infection
por: Imran, Muhammad, et al.
Publicado: (2013)

Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010)

Towards a small animal model for hepatitis C
por: Ploss, Alexander, et al.
Publicado: (2009)

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy
por: Bruening, Janina, et al.
Publicado: (2017)

The Dynamic Relationship between Innate Immune Biomarkers and Interferon-Based Treatment Effects and Outcome in Hepatitis C Virus Infection Is Altered by Telaprevir
por: Malone, David F. G., et al.
Publicado: (2014)

Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus
por: Gaska, Jenna M, et al.
Publicado: (2019)

Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1
por: Perin, Paula M., et al.
Publicado: (2015)

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
por: Wei, Lei, et al.
Publicado: (2021)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4
por: Motawi, Tarek Kamal, et al.
Publicado: (2015)

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms
por: KayvanJoo, Amir Hossein, et al.
Publicado: (2014)

Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions
por: Liu, Yongzhen, et al.
Publicado: (2021)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus?
por: Kim, Do Young
Publicado: (2020)

Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation
por: Wei, Lei, et al.
Publicado: (2020)

Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
por: Sultana, Camelia, et al.
Publicado: (2016)

Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy
por: Itakura, Jun, et al.
Publicado: (2015)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
por: Figlerowicz, Magdalena, et al.
Publicado: (2010)

Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
por: Goyal, Gitanjali, et al.
Publicado: (2016)

Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
por: Re, Valli De
Publicado: (2010)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes, Jacinta A, et al.
Publicado: (2015)

Screening Strategies for Hepatitis C Virus
por: Lim, Aaron G., et al.
Publicado: (2019)

Multi-ancestry Fine Mapping of Interferon Lambda and the Outcome of Acute Hepatitis C Virus Infection
por: Vergara, Candelaria, et al.
Publicado: (2020)

Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
por: Rou, Woo Sun, et al.
Publicado: (2015)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
por: Boldanova, Tujana, et al.
Publicado: (2017)

Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
por: Kim, Do Young
Publicado: (2014)

Hyercalcemia induced by interferon therapy in chronic hepatitis C
por: Albaker, Waleed I.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p0e10q2si35nrjbeumk025lvhv